Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2024

Genmab — Maj 2024

Planlagt Fastgjort Låst Flyttet Genmab
540 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #75

    Cowen höjer riktkursen för Genmab till 2 196 danska kronor (2 104), upprepar behåll - BN (Finwire)
    2024-05-03 06:10

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #76

      AMGEN earnings Q1 '24- TEPEZZA® (teprotumumab-trbw) generated $424 million of sales in the first quarter. -that is as expected; they guided 'expect mid single growth % over Q1 23
      ' and this is ~5% https://www.amgen.com/newsroom/press-releases/2024/05/amgen-reports-first-quarter-2024-financial-results
      https://investors.amgen.com/static-files/c94912ba-7169-4c84-98b6-23a286b2f72d

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #77

        Fornuften vender tilbage +2 % pt.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #78

          undskyld +3 %

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GeorgeBest
            wrote on sidst redigeret af
            #79

            Så er vi forhåbentlig færdige med at krydse kurs 2000

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JKY_VH
              wrote on sidst redigeret af
              #80

              Ja lad os nu blive færdige med det pjat;-)

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #81

                Fra Nordeas morgenkommentar: Genmab (hold) - Toplinjen i Q1 (4,143 mio. kr.) kom ud 7% bedre end konsensus, og EBIT (801 mio. kr.) kom ud ~4% under konsensus. Costs 4% over konsensus. Darzalex in-market salget kom ud 2% over konsensus. Epkinly-salget (DLBCL) var lyspunktet i Q1 rapporten med et salg på 54 mio. USD, som var 38% over konsensus. Fastholder guidance. Ingen pipeline nyheder. GEN1046 data bliver præsenteret på en poster session på ASCO (1/6) - det vidste vi allerede. Non-event.

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #82

                  Underlige divergenser mellem US og dk de seneste dage. Vel samme regnemaskiner de bruger ?

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #83

                    Tænker lidt det samme solsen - nogen der har lagt mærke til volumen i US?

                    1 Reply Last reply
                    0
                    • W Offline
                      W Offline
                      w
                      wrote on sidst redigeret af
                      #84

                      GB, kl10.30 det har jeg tænkt ofte

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #85

                        Ads’en stiger 5,4% premarket. Nogen har fortrudt.

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #86

                          God volume i cph 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            Brit
                            wrote on sidst redigeret af
                            #87

                            Hvis Genmab gør, hvad den har gjort længe, så siver den herfra over den
                            næste periode. Men jeg forstå optimismen lige nu.

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #88

                              Kaveri Pohlman
                              BTIG
                              Buy $46.00 Maintained 3-5-24

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #89

                                Ram Selvaraju
                                H.C. Wainwright
                                Buy $50.00 Reiterated
                                3-5-24

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #90

                                  Asthika Goonewardene
                                  Truist Financial
                                  Buy Maintained 3-5-24 (i think they were at $50)

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #91

                                    Xian Deng
                                    UBS
                                    Buy Kr.2,750.00 Maintained 3-5-24

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #92

                                      Pæn spredning i kursmålene. Gad vide om der er nogen der køber/sælger efter analytikernes anbefalinger ?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #93

                                        if I look at the questions some analysts ask, it doesn't really give me the confidence they are all completely up to date on Genmab...

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          Hugininvest
                                          wrote on sidst redigeret af
                                          #94

                                          many of them are definitely not up to date. maybe a bit of sense is coming to the stock. but still grossly undervalued. God
                                          weekend

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper